Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Operating Expenses
Noevir Holdings Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Operating Expenses
-¥31.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Expenses
-¥881.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Expenses
-¥117.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Expenses
-¥126B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
Kao Corp
TSE:4452
|
Operating Expenses
-¥481.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Expenses
-¥72.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
See Also
What is Noevir Holdings Co Ltd's Operating Expenses?
Operating Expenses
-31.5B
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Operating Expenses amounts to -31.5B JPY.
What is Noevir Holdings Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-3%
Over the last year, the Operating Expenses growth was -1%. The average annual Operating Expenses growth rates for Noevir Holdings Co Ltd have been -9% over the past three years , -4% over the past five years , and -3% over the past ten years .